Literature DB >> 29657945

THE ROLE OF PROTEIN CHAPERONES IN THE SURVIVAL FROM ANTHRACYCLINE-INDUCED OXIDATIVE STRESS IN SACCHAROMYCES CEREVISIAE.

Jana S Miles1, Samantha J Sojourner1, Lahcen Jaafar2, Aurellia Whitmore1, Selina Darling-Reed1, Hernan Flores-Rozas1.   

Abstract

Several S. cerevisiae deletion strains involving heat-shock response factors were among the most sensitive mutants identified in a previous genetic screen for doxorubicin hypersensitivity. These strains included ydj1Δ, ssz1Δ and zuo1Δ mutants. In addition, new1Δ, whose function was unknown, also displayed significant sensitivity to anthracyclines. We further investigated the basis for the sensitivity of these mutants. We determined that heat-shock could partially rescue the sensitivity of the strains to doxorubicin, including the homologous recombination mutant rad52Δ, which is sensitive to doxorubicin-mediated DNA double strand breaks (DSBs). However, none of the heat-shock response mutants were sensitive to DSBs, but were highly sensitive to reactive oxygen species (ROS) generated by quinone-ring-containing agents, such as anthracyclines and menadione. A fluorescent-based assay indicates that doxorubicin causes protein aggregation. Interestingly, the disaggregase mutant hsp104Δ is not sensitive to anthracyclines or menadione suggesting that Hsp104p does not play a role in disaggregating doxorubicin-induced protein aggregates. However New1p, which has been recently shown to be a novel disaggregase, is essential for cell viability after exposure to anthracyclines and menadione and it is not involved in thermotolerance. Our data suggest that in S. cerevisiae, doxorubicin produces protein aggregation through ROS and requires Ydj1p and New1p for resolution.

Entities:  

Keywords:  Anthracyclines; Cancer; Heat-Shock Response; Molecular Chaperones; Oxidative Stress

Year:  2018        PMID: 29657945      PMCID: PMC5894877     

Source DB:  PubMed          Journal:  Int J Adv Res (Indore)        ISSN: 2320-5407


  35 in total

Review 1.  The heat shock response: life on the verge of death.

Authors:  Klaus Richter; Martin Haslbeck; Johannes Buchner
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

Review 2.  Targeting heat shock proteins in cancer.

Authors:  Gaëtan Jego; Adonis Hazoumé; Renaud Seigneuric; Carmen Garrido
Journal:  Cancer Lett       Date:  2010-11-13       Impact factor: 8.679

Review 3.  Remodeling of protein aggregates by Hsp104.

Authors:  John R Glover; Ronnie Lum
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

Review 4.  The unfolded protein response as a target for cancer therapy.

Authors:  Anika Nagelkerke; Johan Bussink; Fred C G J Sweep; Paul N Span
Journal:  Biochim Biophys Acta       Date:  2014-07-25

Review 5.  Protein oxidation in aging, disease, and oxidative stress.

Authors:  B S Berlett; E R Stadtman
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

6.  Heart transplant survival outcomes for adriamycin-dilated cardiomyopathy.

Authors:  Andrew J Lenneman; Li Wang; Mark Wigger; Haydar Frangoul; Frank E Harrell; Cheri Silverstein; Douglas B Sawyer; Carrie G Lenneman
Journal:  Am J Cardiol       Date:  2012-11-27       Impact factor: 2.778

7.  Elevated glutathione is not sufficient to protect against doxorubicin-induced nuclear damage in heart in multidrug resistance-associated protein 1 (Mrp1/Abcc1) null mice.

Authors:  Jun Deng; Donna Coy; Wei Zhang; Manjula Sunkara; Andrew J Morris; Chi Wang; Luksana Chaiswing; Daret St Clair; Mary Vore; Paiboon Jungsuwadee
Journal:  J Pharmacol Exp Ther       Date:  2015-09-09       Impact factor: 4.030

Review 8.  Neoadjuvant treatments for triple-negative breast cancer (TNBC).

Authors:  G von Minckwitz; M Martin
Journal:  Ann Oncol       Date:  2012-08       Impact factor: 32.976

Review 9.  DNA topoisomerase II structures and anthracycline activity: insights into ternary complex formation.

Authors:  D Dal Ben; M Palumbo; G Zagotto; G Capranico; S Moro
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

Review 10.  Dexrazoxane for the treatment of chemotherapy-related side effects.

Authors:  Seppo W Langer
Journal:  Cancer Manag Res       Date:  2014-09-15       Impact factor: 3.989

View more
  3 in total

1.  Doxorubicin induces large-scale and differential H2A and H2B redistribution in live cells.

Authors:  Péter Nánási; László Imre; Erfaneh Firouzi Niaki; Rosevalentine Bosire; Gábor Mocsár; Anett Türk-Mázló; Juan Ausio; Gábor Szabó
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

2.  Evaluation of the Role of Human DNAJAs in the Response to Cytotoxic Chemotherapeutic Agents in a Yeast Model System.

Authors:  Aurellia Whitmore; Devon Freeny; Samantha J Sojourner; Jana S Miles; Willie M Graham; Hernan Flores-Rozas
Journal:  Biomed Res Int       Date:  2020-02-13       Impact factor: 3.411

3.  The cellular response to drug perturbation is limited: comparison of large-scale chemogenomic fitness signatures.

Authors:  Marjan Barazandeh; Divya Kriti; Corey Nislow; Guri Giaever
Journal:  BMC Genomics       Date:  2022-03-11       Impact factor: 3.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.